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Abstract
Objective Recent literature has shown that common type
atrial flutter (AFL) can recur late after cavotricuspid isthmus
(CTI) catheter ablation using radiofrequency energy (RF).
We report the long term outcome of a large group of patients
undergoing CTI ablation using cryothermy for AFL in a
single center.
Methods Patients with AFL referred for CTI ablation were
recruited prospectively from July 2001 to July 2006.
Cryoablation was performed using a deflectable, 10.5 F,
6.5 mm tip catheter. CTI block was reassessed 30 min after
the last application during isoproterenol infusion. Recurrences
were evaluated by 12-lead ECG and 24 h Holter recording
every clinic visit (1/3/6/9 and 12 months after the procedure
and yearly thereafter) or if symptoms developed.
Results The 180 enrolled patients had the following
characteristics: 39 women (22%), mean age 58 years, no
structural heart disease in 86 patients (48%), mean left atrium
diameter 44±7 mm and mean left ventricular ejection
fraction 57±7%. The average number of applications per
patient was 7 (3 to 20) with a mean temperature and duration
of −88°C and 3 min, respectively. Acute success was
achieved in 95% (171) of the patients. There were no
complications. After a mean follow-up of 27±17 (from 12 to
60) months, the chronic success rate was 91%. The majority
of the recurrences occurred within the first year post ablation.
One hundred and twenty three patients had a history of atrial
fibrillation (AF) prior to CTI ablation and 85 (69%) of those
remained having AF after cryoablation. In 20 of 57 (35%)
patients without a history of AF prior to CTI ablation, AF
occurred during follow-up.
Conclusions This prospective study showed a 91% chronic
success rate (range 12 to 60 months) for cryoablation of the
CTI in patients with common type AFL and ratified the
frequent association of AF with AFL.
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1 Introduction
Ablation of the cavotricuspid isthmus (CTI) for the
treatment of atrial flutter (AFL) has become standard
practice. Most of the procedures are performed using
radiofrequency energy (RF) [1–5]. High chronic success
rates are described but the majority of the data comes from
a relatively short term follow-up [1–13]. A recent study by
Chinitz et al. [14] reported some interesting data regarding
the long term follow-up of 80 patients with common type
AFL who underwent CTI ablation using RF. They found a
12.5% (ten patients) recurrence rate at an average of
21 months after the procedure with most patients having a
recurrence after the first year post ablation. Our prior
experience using cryothermy in a limited number of patients
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Maastricht, The Netherlands[15] also showed that AFL may recur 1 year after CTI
cryoablation.
The purpose of this study was to evaluate the long term
outcome of CTI cryoablation in a large patient population
with common type AFL in a single center.
2 Methods
One hundred and eighty patients with sustained symptomatic
common type AFL referred for CTI ablation were enrolled
prospectively from July 2001 to July 2006 in our institution.
Signed written consent, approved by the local ethics
committee, was obtained from all participants.
Before CTI cryoablation, anticoagulation with warfarin
aiming a therapeutic international normalized ratio of 2 to 3
was kept for at least 3 weeks. Antiarrhythmic drugs were
not discontinued before ablation.
2.1 Electrophysiologic study and ablation
We focused our study on the clinical aspects and long term
follow-up of patients with AFL who were submitted to CTI
cryoablation.
Our CTI cryoablation protocol has been already reported
[15]. Briefly, our methodology was as follows: under local
anesthesia and via the femoral route, a decapolar catheter
is positioned in the distal coronary sinus (for evaluation of
left atrial activation), a duodecapolar catheter (2-mm
interelectrode spacing, Halo catheter, Biosense Webster,
Baldwin Park, CA) for mapping the right atrial lateral wall
and a quadripolar catheter in the His bundle area. A
deflectable, 10.5 F, 6.5 mm tip cryoablation catheter (CryoCor
Inc., San Diego, CA) is inserted into the right atrium through
a 12F, 65-cm-long sheath (DAIG, St. Jude Medical Inc., St.
Paul, MN) [15–19].
Entrainment to confirm the isthmus dependence of the
AFL circuit was performed in every patient in whom AFL
was present or could be induced at the start of the
procedure, according to previously published techniques
[2, 10, 15, 16, 20, 21]. If AF, requiring cardioversion, was
present or developed during stimulation or if we were
unable, even under isoproterenol infusion, to induce AFL,
CTI ablation was performed during sinus rhythm. Linear
lesions were created by use of a point-by-point technique
with gradual pullback of the cryocatheter in a ventricular
atrial fashion. The first application was delivered at the
ventricular insertion of the isthmus and applications were
continued for an average of 3 min. In patients in whom
ablation of the posterior isthmus proved insufficient, an
attempt was made to ablate the septal isthmus (four
patients). After documentation of bidirectional isthmus
conduction block, the atrial pacing (from the proximal
coronary sinus) protocol (up to three atrial extrastimuli at
three pacing cycle lengths and incremental atrial pacing)
was performed without and with isoproterenol infusion (1
to 3 μg/min). Acute success was defined as bidirectional
isthmus conduction block, 30 min after the last application
without and with isoproterenol infusion [22].
All patients were studied in the fasting state without
sedation. Those presenting in AF while on the catheterization
table were converted to sinus rhythm by internal or external
cardioversion. During the procedure intravenous heparin was
given as a 100-IU/kg bolus dose after the venous sheaths
were inserted. The 12-lead ECG and intracardiac electro-
grams were recorded and stored by the BARD Labsystem
PRO.
2.2 Post ablation management
All patients were monitored in hospital for 24 h and oral
anticoagulation was started the day of ablation. Antiar-
rhythmic drugs (AAD) were stopped after the procedure in
patients without a history of AF; in those with AF/AFL the
same AAD were continued. All patients had anticoagulation
for at least 1 month. Subsequently, the need for chronic
anticoagulation was assessed by the amount of recurrences of
AFL/AF and the presence of risk factors for thromboembolic
events.
All patients had a 12-lead ECG and a 24 h Holter
recording at discharge and during each clinic visit (1 month,
3, 6, 9, 12 months and yearly thereafter) or earlier if they
had symptoms.
Due to the logistics of the Maastricht area—and also the
presence of a dedicated research nurse (S. P.) who was
available to address patients’ concerns and questions at any
time—we were able to follow every patient on an
individual basis.
2.3 Statistical analysis
Continuous variables are presented as mean±SD, where
appropriate. In cases of a non-Gaussian distribution,
medians and quartiles are given. Categorical variables are
expressed as numbers and percentages of patients.
Statistical analysis was performed using the Student t test
for unpaired data. All values were considered significant at
P<0.05.
The authors had full access to the data and take
responsibility for its integrity.
3 Results
Of the 180 enrolled patients, 39 patients (22%) were
women with a mean age of 58 (from 18 to 80) years. More
236 J Interv Card Electrophysiol (2008) 21:235–240than half of the patients (92 patients, 52%) had structural
heart disease: arterial hypertension: 57 patients, coronary
artery disease: 22 patients, valvular heart disease: 13
patients, congenital heart disease: 11 patients, idiopathic
cardiomyopathy: 18 patients. Counterclockwise AFL was
documented in 91% (164) of the patients and clockwise
AFL in 9% (16 patients).
The mean left atrial diameter and the mean left
ventricular ejection fraction were 44±7 mm and 57±7%,
respectively. A prior history of AF was present in 123
(69%) of the patients. The clinical characteristics of the
patients, related to the presence or absence of AF before
ablation, are described in Table 1. Note that AF during
follow-up is significantly higher in the group with a prior
history of this arrhythmia.
Total fluoroscopic—mean of 30±18 min (range, 12 to
152 min)—and procedure times—mean of 2.6±1.1 h
(range, 1 to 6.5 h)—decreased throughout our study with
a long duration of a procedure and fluoroscopy being
attributed mainly to the learning curve of a new technology.
An average of 7 (3 to 20) applications per patient were
delivered with a mean temperature and duration of −88°C
and 3 min, respectively.
The acute success rate for cryoablation of the CTI was
95% (171 patients). There were no complications. Of the
nine patients in whom bidirectional CTI block was not
achieved, three underwent a successful reablation. The
other six patients had much improvement of their symp-
toms (despite an incomplete line) and preferred not to have
another procedure.
After a mean follow-up of 27±17 (range from 12 to 60)
months, recurrences of symptomatic AFL occurred in 15
patients (9%) resulting in a 91% chronic success rate.
Those recurrences occurred in six patients within the first
3 months post ablation, in four patients from 3 to 6 months
post ablation, in four patients from 6 to 9 months post
ablation and in one patient at 14 months post ablation
(Fig. 1). Ten of those 15 patients underwent a second
successful cryoablation of the CTI. The other five had not
only reablation of the isthmus but also pulmonary vein
cryoisolation (PVI) for AF during the second procedure.
Despite the success as far as AFL was concerned, AF
was still present in 85 patients (69%) with a prior history of
this arrhythmia. Those patients were treated by AAD (69
patients, 81%), PVI (14 patients, 16%) or AV nodal
ablation with pacemaker implantation (two patients, 3%).
New episodes of AF developed in 20 (35%) of those 57
patients without documented AF prior to CTI cryoablation
and were all controlled by AAD.
4 Discussion
4.1 Main findings
Our current study showed a 91% chronic success rate of
CTI cryoablation in a large population (180 patients) with
AFL followed for a long period of time (1 to 5 years, mean
of 27 months).
According to the most recent ACC/AHA/ESC guidelines
for the management of supraventricular arrhythmias CTI
ablation is the only therapy with a class I indication for the
long term management of AFL [2]. The majority of those
ablations are done using RF energy. Concerning the follow-
up length of those procedures, most of the literature
available reports on a relatively short period, the majority
of them being less than 2 years. However Chinitz et al. [14]
published a study of 80 patients with AFL submitted to CTI
ablation using RF that had up to 6 years follow-up.
Interestingly, they found a 12.5% recurrence of AFL that
occurred on an average of 21 months post ablation,
ratifying the need of data with a longer follow-up. It is
important to keep in mind though, that arrhythmias after
ablation do not always correlate with symptoms [23, 24]
and one could question if those patients with such a late
recurrence had those episodes much earlier than what is
reported. That might be one reason why our results, where
most of our recurrences happened within 1 year, are
Table 1 Characteristics of the 180 patients with atrial flutter referred for CTI cryoablation related to the presence or absence of atrial fibrillation
AF before ablation
AF/AFL patients (123 patients), 69% AFL only (57 patients), 31% p value
Age (year) 57±13 58±13 ns
Women 19% (23 patients) 28% (16 patients) ns
No SHD 55% (68 patients) 32% (18 patients) < 0.05
LAd (cm) 4.4 4.5 ns
LVEF (%) 58 55 ns
Acute failures
a 5% (6 patients) 5% (3 patients) ns
AF in long term follow up 69% (85 patients) 35% (20 patients) < 0.05
aPatients in whom CTI cryoablation did not result in bidirectional block (failed procedure).
AF Atrial fibrillation, AFL atrial flutter, CTI cavotricuspid isthmus, Lad left atrium diameter, LVEF left ventricular ejection fraction, SHD
structural heart disease
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characteristics of our hospital, our clinical follow-up and
the population of Maastricht could be responsible for our
ability to find those recurrences earlier.
Regarding cryothermy as energy source, a 9 months
follow-up study in 39 patients undergoing CTI cryoablation
with a different system was reported [25]. They achieved a
chronic success rate of 100% in the cryoablated group,
despite documenting reconduction through the isthmus in
31% of patients during a 3 month follow-up electrophys-
iologic study. The CRAAFT trial presented the results in 32
patients with AFL submitted to either cryo- or RF ablation
of the CTI [26]. They report an 84% success rate after a
follow-up of 14 months. Those two small studies, with a
relatively short follow-up, reported similar success rates
with RF and cryothermy for AFL ablation. The results from
our study—which included a significant larger patient
population (180) with a longer follow-up (1 to 5 years,
mean of 27 months)—reinforces the effectiveness of
cryothermy for the treatment of AFL, being the outcomes
comparable to those reported in the literature using RF
(where most outcome data also comes from non invasive
follow-up) [1, 4–7, 11, 12, 27, 28]. Therefore, cryothermy
can be considered as an efficient energy source for the
treatment of common type AFL.
4.2 The relation of AF with AFL
The close relation between AF and AFL is well described
[1, 5–14, 21, 29–39]. Our data showed a high prevalence of
AF (123 out of 180 patients, 69%) in patients with
predominant AFL referred for CTI ablation. A recent study
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association. They followed 363 patients with lone AFL who
underwent CTI RF ablation—during a mean follow-up of
39 months—and reported an 82% incidence of drug
refractory AF in their patient population.
The new development of AF in our patient population
without a prior history of AF preceding AFL ablation may
be a sign of an already present electrical and morphological
change in the right and left atria. If in addition, a functional
or anatomical line of block between the two venae cavae
(or elsewhere) occurs, atypical AFL(s) may develop either
in the right (because the CTI is already ablated) or in the
left atrium [11, 14, 21, 31, 32, 37–39].
4.3 Study limitations
Our recurrence data rely mostly on the subjective assess-
ment by the patient, like the great majority of RF data [1, 4,
6–8, 12]. Only an objective measurement (such as a repeat
electrophysiological study with documented bidirectional
block) will determine the long lasting effect of CTI ablation
for the treatment of common type AFL.
5 Conclusions
In this prospectively studied large population of patients
with common type AFL, cryoablation of the CTI has a 91%
chronic success rate during long term follow-up (range 1 to
5 years, mean of 27 months). These results are similar to
those obtained with RF, validating cryothermy as an
efficient alternative energy source. We also were able to
ratify the frequent association of AF with AFL.
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